Literature DB >> 21457252

New daily persistent headache: a syndrome, not a discrete disorder.

Peter J Goadsby1.   

Abstract

The term New Daily Persistent Headache (NDPH) has been used for nearly 25 years and yet the entity remains enigmatic. It can be argued the simplest, indeed most appropriate, approach is to use the term to mean simply what it says- i.e. as an umbrella description, rather like chronic daily headache. NDPH should be used as a diagnostic umbrella inviting better characterization, not be an achievement in itself. This would mean the term required no further elaboration- there would be no mimics- simply primary and secondary NDPH. A detailed examination of the literature reveals considerable heterogeneity in the phenotypic descriptions labelled as NDPH. The first effort in a patient with a NDPH presentation is to discern if secondary causes are present; some are obvious, such as subarachnoid bleeds and some can be more troublesome, such as syndromes of abnormal CSF pressure/volume, either high or low. A cohort of primary NDPH headaches can be seen in practice and in the literature and these should be sub-divided into a migrainous type, with appropriate phenotypic manifestations and a featureless type. Patients with any one of the NDPH presentations are best managed according to the more detailed pathophysiology-based diagnosis then lumped together into a single group, since a single disorder is unlikely to exist.
© 2011 American Headache Society.

Entities:  

Mesh:

Year:  2011        PMID: 21457252     DOI: 10.1111/j.1526-4610.2011.01872.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  7 in total

1.  New daily persistent headache and radiologically isolated syndrome.

Authors:  Diana Aguiar de Sousa; Ruth Geraldes; Raquel Gil-Gouveia; João Correia de Sá
Journal:  J Neurol       Date:  2013-07-09       Impact factor: 4.849

Review 2.  New daily persistent headache and potential new therapeutic agents.

Authors:  Shivang G Joshi; Paul G Mathew; Herbert G Markley
Journal:  Curr Neurol Neurosci Rep       Date:  2014-02       Impact factor: 5.081

3.  Outcomes of greater occipital nerve injections in pediatric patients with chronic primary headache disorders.

Authors:  Amy A Gelfand; Amanda C Reider; Peter J Goadsby
Journal:  Pediatr Neurol       Date:  2013-11-20       Impact factor: 3.372

4.  [Therapy and care of patients with chronic migraine: expert recommendations of the German Migraine and Headache Society/German Society for Neurology as well as the Austrian Headache Society/Swiss Headache Society].

Authors:  A Straube; C Gaul; S Förderreuther; P Kropp; M Marziniak; S Evers; W H Jost; H Göbel; C Lampl; P S Sándor; A R Gantenbein; H-C Diener
Journal:  Nervenarzt       Date:  2012-12       Impact factor: 1.214

5.  European Headache Federation consensus on technical investigation for primary headache disorders.

Authors:  D D Mitsikostas; M Ashina; A Craven; H C Diener; P J Goadsby; M D Ferrari; C Lampl; K Paemeleire; J Pascual; A Siva; J Olesen; V Osipova; P Martelletti
Journal:  J Headache Pain       Date:  2016-02-09       Impact factor: 7.277

6.  Short-term diagnostic stability of probable headache disorders based on the International Classification of Headache Disorders, 3rd edition beta version, in first-visit patients: a multicenter follow-up study.

Authors:  Byung-Su Kim; Heui-Soo Moon; Jong-Hee Sohn; Myong-Jin Cha; Tae-Jin Song; Jae-Moon Kim; Jeong Wook Park; Kwang-Yeol Park; Soo-Jin Cho; Soo-Kyoung Kim
Journal:  J Headache Pain       Date:  2016-02-19       Impact factor: 7.277

7.  Comparison and predictors of chronic migraine vs. new daily persistent headache presenting with a chronic migraine phenotype.

Authors:  Karthik Nagaraj; Diana Y Wei; Francesca Puledda; Hsing-Yu Weng; Sadaf Waheed; Nicolas Vandenbussche; Jonathan J Y Ong; Peter J Goadsby
Journal:  Headache       Date:  2022-07-21       Impact factor: 5.311

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.